# Role of Inflammatory Markers in Sepsis

> **NCT06111963** · — · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 60 (actual)

## Conditions studied

- Diagnostic

## Interventions

- **DIAGNOSTIC_TEST:** Serology tests

## Key facts

- **NCT ID:** NCT06111963
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2025-01-05
- **Final completion:** 2025-01-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111963, "Role of Inflammatory Markers in Sepsis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06111963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*